Logistics specialist Chasen's subsidiaries bag S$11.4m of projects
MAINBOARD-listed logistics specialist Chasen Holdings announced its subsidiaries in Malaysia, Vietnam and China had recently bagged four projects worth some S$11.4 million in total.
The Malaysian project is valued at RM6.6 million (S$2.2 million), Chasen said, and was awarded to its Penang-based subsidiary, Chasen Logistics Sdn Bhd, by a US solar manufacturer.
The same US company also awarded a similar contract to Chasen's Vietnam subsidiary, Chasen Transport Logistics, involving the uncrating, rigging, marking and positioning of machinery and tools on the manufacturing floor.
The move-in of the Malaysian plant began late October 2017 and is expected to be done in May 2018, while the Vietnam plant is expected to be completed in July this year.
Meanwhile, Chasen's China subsidiary, Chasen Hi-Tech Machinery Services, signed two projects worth 36 million yuan (S$7.5 million) in total.
The first project, valued at 16 million yuan, is for rigging and move-in positioning of tools and equipment for the pilot line of an "11th generation TFT LCD manufacturing plant" in Shenzhen.
The second project worth 20 million yuan is for managing the temporary warehouse and move-in of equipment for a "6th generation AMOLED plant" in Mianyang City, Sichuan province.
Low Weng Fatt, managing director and Chasen's chief executive, said the projects are expected to contribute positively to the company's operations for financial years 2018 and 2019.
Chasen's counter was down 0.1 Singapore cent, or 1.39 per cent to finish at 7.1 Singapore cents before the announcement was made.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Air China to buy 100 locally made C919 jets in US$11 billion deal
HCA beats first-quarter profit estimates on higher patient admissions
F&B operator YKGI to exclusively operate Chicha San Chen in Macau for next eight years
LMIRT Q1 net property income dips 3.1% to S$30 million on higher expenses
Exxon misses on Q1 profit despite big gains in Guyana
US FDA approves Pfizer’s gene therapy for rare bleeding disorder